Core Viewpoint - Greenme Co., Ltd. is planning to issue H shares and list them on the Hong Kong Stock Exchange, necessitating amendments to its Articles of Association and related rules [1]. Summary by Sections Company Announcement - The Board of Directors approved the proposal to amend the Articles of Association and related rules to accommodate the issuance of H shares [1]. - The proposal will be submitted for approval at the fourth extraordinary general meeting of shareholders in 2025 [1]. Amendments to Articles of Association - The amendments aim to protect the rights of shareholders, employees, and creditors, and to regulate the company's organization and behavior according to relevant laws and regulations [2][3]. - The new draft of the Articles of Association will take effect upon the listing of H shares on the Hong Kong Stock Exchange [1]. Specific Amendments - The Articles of Association will include provisions for the issuance of H shares and the management of shareholder rights [5][6]. - The company will maintain a shareholder register that complies with both domestic and international regulations [14][15]. Shareholder Rights and Responsibilities - Shareholders will have rights to dividends and other benefits proportional to their shareholdings [19]. - Shareholders are required to comply with laws, regulations, and the Articles of Association [20]. Governance and Decision-Making - The company will establish rules for convening shareholder meetings and making decisions, including the requirement for a certain percentage of shareholder attendance for resolutions [24][36]. - The company will ensure that decisions affecting minority shareholders are transparently reported [41].

证券代码：002340 证券简称：格林美 公告编号：2025-083 格林美股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 格林美股份有限公司（以下简称"公司"）第七届董事会第六次会议通知已于 议于2025年8月21日在荆门市格林美新材料有限公司会议室以现场和视频相结合 的表决方式召开。本次会议应参加会议的董事6人，实际参加会议的董事6人。出 席会议的人数超过董事总数的二分之一，表决有效。会议由公司董事长许开华先 生主持，会议召开的时间、地点及方式均符合《中华人民共和国公司法》及《公 司章程》的有关规定。 二、董事会会议审议情况 | 号 | | 情况 | 东会审议 | | --- | --- | --- | --- | | 序 | | 变更 | 是否提交股 | | | 制度名称 | | | 号 情况 东会审议 修订及制定后的制度全文详见公司指定信息披露媒体巨潮资讯网 （http://www.cninfo.com.cn）披露的相关内容。 （一）会议以6票同意、0票反对、0票弃权，审议通过了《关于修订 <公司> 章程>及相关议 ...

Group 1 - Yangzhou Xiyue has received feedback from the China Securities Regulatory Commission (CSRC) regarding its application for overseas listing in the United States [1] - The CSRC has requested clarification on the compliance of the company's equity control structure, including foreign exchange management and tax compliance [1] - The company was asked to explain the reasons why Hu Jiahui, the spouse of the actual controller Xiong Bin, was not recognized as a joint actual controller [1] Group 2 - The CSRC requires Yangzhou Xiyue to provide details on the shareholding structure before and after the equity restructuring, including any inconsistencies in shareholding ratios [1] - The company must clarify the pricing and payment details related to the capital increase of Andaman Construction in Hangzhou Wukong and other entities [1] - The CSRC has also requested information on the fairness and compliance of zero-cost transfers of shares in certain subsidiaries [1] Group 3 - The CSRC has asked for additional information regarding related party loans provided by Hangzhou Jialin to various entities, including the background and repayment arrangements [2] - The company needs to disclose the registered capital payment status of its domestic entities and any implications for normal business operations [2] - There is a requirement to explain the implications of a frozen shareholding in a subsidiary and its potential impact on the listing process [2] Group 4 - Yangzhou Xiyue must provide details on its business operations, including compliance with foreign investment restrictions and the nature of its subsidiaries' activities [2][3] - The company is required to clarify its digital business practices, including data collection and user information protection measures [3] - The company was established in 2024 in Jiangsu Province, focusing on software and information technology services, with a registered capital of 3 million RMB [3][4]

Core Viewpoint - The article discusses the recent requirements for supplementary materials for overseas listing applications by the China Securities Regulatory Commission (CSRC), highlighting the ongoing trend of companies seeking to list on the Hong Kong Stock Exchange, with a focus on compliance and regulatory scrutiny [2][3][4]. Group 1: Supplementary Material Requirements - A total of 36 companies have been requested to provide supplementary materials for their overseas listing applications, primarily targeting the Hong Kong IPO market [2]. - Specific companies such as Lin Qingxuan and Yangzhou Xiyue have been highlighted for particular compliance issues regarding shareholder equity transfers and the legality of their corporate structures [3][4]. - Companies like Huafu Yang and Jiewate are required to clarify the pricing and compliance of their capital increase and reduction processes, ensuring adherence to foreign investment regulations [4][15]. Group 2: Compliance and Regulatory Issues - Companies must provide detailed explanations regarding their shareholder structures, including any discrepancies in the identification of controlling shareholders and the implications for their listing applications [4][18]. - The article emphasizes the importance of legal opinions from lawyers to confirm the compliance of corporate actions with relevant regulations, particularly concerning foreign investment and tax obligations [6][7][8]. - Companies are also required to disclose their operational compliance with foreign investment restrictions, especially in sectors listed in the negative list for foreign investment [35][36][37]. Group 3: Specific Company Cases - Lin Qingxuan is under scrutiny for the pricing and rationale behind recent shareholder equity transfers, as well as the tax implications for the involved parties [43]. - Yangzhou Xiyue faces questions regarding the fairness and legality of zero-cost equity transfers made by its shareholders [12][13]. - Basic Semiconductor must clarify the reasons for inconsistencies in the identification of its controlling shareholders and provide a conclusive opinion on its compliance status [18]. Group 4: Industry Trends - The article indicates a robust interest in Hong Kong IPOs among Chinese companies, reflecting a broader trend of seeking international capital markets for growth [2]. - The regulatory environment is tightening, with increased scrutiny on corporate governance and compliance practices, which may impact the speed and success of overseas listings [4][5]. - The focus on compliance with foreign investment regulations suggests a shift towards greater transparency and accountability in the corporate sector [35][36].

Group 1 - The company held its 31st meeting of the 4th Board of Directors on August 22, 2025, to discuss various governance matters [1] - The Board approved amendments to the company's Articles of Association and related rules to enhance corporate governance and compliance with legal requirements [2][3] - The Board agreed to seek shareholder approval for the issuance of H shares and listing on the Hong Kong Stock Exchange to further the company's international strategy [3][4] Group 2 - The proposed H share issuance will involve a maximum of 15% of the company's total share capital post-issuance, with an option for overallotment [6] - The issuance will be conducted through a public offering in Hong Kong and an international placement, with specific allocation strategies based on market conditions [5][7] - The company plans to use the proceeds from the H share issuance for network expansion, product development, brand building, and other strategic initiatives [9][10] Group 3 - The Board approved a plan for the company to transition into an overseas fundraising company following the successful issuance and listing of H shares [9][10] - The company will revise its internal governance documents to align with the new structure and regulatory requirements post-listing [18][24] - The Board proposed to establish a confidentiality and archival management system related to the overseas issuance and listing [27]

Core Viewpoint - The company, Sinovac Biotech (688136), is planning to issue overseas listed shares (H shares) and list on the Hong Kong Stock Exchange to enhance its international business development and brand image while optimizing its capital structure and diversifying financing channels [1]. Group 1 - The company aims to deepen its "innovation + internationalization" strategic layout [1]. - The initiative is intended to accelerate the development of overseas business and improve the company's overall competitiveness [1]. - The company is currently in discussions with relevant intermediaries regarding the specific progress of the H share listing, with details yet to be finalized [1].

格隆汇8月22日丨科兴制药(688136.SH)公布，公司为加快海外业务发展，进一步提高公司综合竞争力及 国际品牌形象，同时充分借助国际资本市场的资源与机制优势，优化资本结构，拓宽多元融资渠道，公 司正在筹划发行境外上市股份(H 股)并在香港联合交易所有限公司上市(以下简称"本次 H 股上市")。公 司正与相关中介机构就本次H股上市的具体推进工作进行商讨，相关细节尚未确定。 ...

Group 1 - The stock price of Liou Co., Ltd. experienced significant fluctuations, with a cumulative increase of over 20% in three consecutive trading days, triggering stock price anomaly regulations [2] - Liou Co., Ltd. is planning to issue shares overseas (H-shares) and list on the Hong Kong Stock Exchange, aiming to enhance its international brand image and financing capabilities [2] - The company's main business is weak, relying heavily on investment income, and its actual controller is under regulatory investigation, raising concerns about the legitimacy of the planned Hong Kong listing [2][6] Group 2 - Liou Co., Ltd. has maintained revenue above 20 billion RMB for several years, with its largest business segment being media agency services, but its growth has stagnated compared to competitors [3][4] - In 2024, Liou Co., Ltd. held a market share of approximately 3% in the media agency sector, significantly trailing behind the leading company, which had a market share of 24% [3][4] - The company has announced plans to use up to 3 billion RMB of its own funds for diversified securities investments, indicating a focus on stock market activities [6] Group 3 - The actual controller of Liou Co., Ltd. is under investigation for suspected insider trading, which may pose challenges for the company's planned overseas listing [6][7] - The investigation involves transactions made by the controller's family member, which have been classified as short-term trading, resulting in a loss [6] - The company asserts that the investigation does not affect its operations and that it will comply with regulatory requirements during this period [7] Group 4 - Liou Co., Ltd. has shown concerning financial metrics, with gross profits fluctuating between 1.3 billion to 1.9 billion RMB, leading to questions about the stability of its business model [8] - The company has reported negative cash flow for four consecutive years from 2021 to 2024, raising doubts about the authenticity of its reported profits [9] Group 5 - Liou Co., Ltd. has engaged in significant related-party transactions, including a recent agreement with a company controlled by its actual controller for construction and engineering services [12][13] - The company claims that these transactions are conducted at market prices and do not harm the interests of the company or its shareholders [13]

科兴制药公告，公司正在筹划发行境外上市股份(H股)并在香港联合交易所有限公司上市。此举旨在深 化"创新+国际化"战略，加快海外业务发展，提高综合竞争力及国际品牌形象，优化资本结构，拓宽融 资渠道。相关细节尚未确定，需提交公司董事会和股东大会审议，并取得相关政府机构、监管机构备 案、批准或核准。本次H股上市能否通过审议、备案和审核程序并最终实施具有不确定性。 ...

华勤技术（603296）(603296.SH)发布公告，为加快公司的国际化战略及海外业务发展，增强公司的境 外融资能力，进一步提高公司的综合竞争力，根据公司总体发展战略及运营需要，公司拟发行境外上市 股份(H股)并在香港联合交易所有限公司(以下简称"香港联交所")主板上市。 ...